List of Radiopharmaceuticals/Radiotherapies Companies in Texas - 7

Nasal breathing is a very important function of human life and any obstruction in the nasal airway also known as a congested or blocked nose, can dramatically impact the quality of life.The VIVAER treatment, performed in a doctor’s office, is a non-invasive procedure without any incisions. The patient'snasal valve area is gently reshaped using low-temperature radiofrequency energy with lasting results.

Fuzionaire Theranostics is a radiopharmaceutical company on a mission to make theranostic treatments more accessible to people with cancer. With origins in Nobel laureate Robert Grubbs' lab at Caltech, the company's patented HetSiFA® platform offers manufacturing advantages in a clinical setting and enables a personalized therapeutic dose for each cancer patient. Current development plans address pressing clinical needs in prostate and lung cancer. For more, visit us at: www.fuzionairetx.com

We develop novel therapeutic and diagnostic agents directed at severe diseases. Our specialty is therapeutic radiopharmaceuticals. IsoTherapeutics has been acquired by Telix Pharmaceuticals.

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium NanoLiposomes, a patented radiotherapy for patients with recurrent glioblastoma, which is in the Phase 1 dose-finding clinical trial. The company is also developing DocePLUS, a patented chemotherapy for patients with solid tumors that is in Phase 1 clinical trial; and DoxoPLUS, a generic chemotherapy for patients with ovarian cancer. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx’s glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radio-pharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radio-labeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology. RadioMedix is introducing the SmartMedix™ automated laboratory system for synthesis of PET tracers for the research and clinical markets. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for clinical probe development and Molecular Imaging Facility for evaluation of agents in animal models.

Starget Pharma is a clinical stage company developing a pipeline of radioligand therapy programs generated using its proprietary Backbone Dynamics peptide platform that leverages backbone cyclic innovations and in-silico AI to rapidly design highly specific Smart Targeted Radioligands (STRs) that deliver focused radiation for the imaging and treatment of hard-to-treat cancers.

Stratus® Medical's mission is to improve clinical outcomes for chronic pain patients by advancing RF technology for the treatment of pain. The Nimbus® RF Multitined Expandable Electrode, in combination with an RF Generator and Probe, are intended for use in radiofrequency (RF) heat lesion procedures for the treatment of pain. Nimbus creates a large volume and optimally shaped lesion. Nimbus provides faster procedure times, lower cost and reproducible and durable pain relief. The Nimbus RF procedure takes about 20 minutes and is completed in a procedure suite in the office, ASC or hospital outpatient department. Patients can be treated while awake with numbing medication or sedated, depending on physician and facility preference. Nimbus has 37 issued patents, several patents pending, is FDA cleared (class II) and is CE marked (class IIb). Nimbus has been utilized in over 250,000 patient treatments in the United States, Australia, Brazil, Canada, United Kingdom, and other countries. Stratus Medical also markets complimentary technology including Vesta®, Nimbus Probe and Nimbus Disposable Probe and has several exciting development projects underway. Copyright © Stratus Medical 2024 Nimbus®, Stratus® Medical & Advancing RF Technology for the Treatment Pain® are registered trademarks of Stratus Medical, LLC. *The Nimbus RF Multitined Expanandable Electrode is one treatment option for pain. Consult your physician for medical questions about your specific pain condition & treatment options. Nimbus RF results will vary. See IFU for full list of warnings and precautions.